Local Recurrence and Disease-Specific Mortality Outcomes in Patients With Invasive Melanoma Treated With Mohs Micrographic Surgery With Melanocytic Immunostains
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Mohs Micrographic Surgery With Melanocytic Immunostains for T1a/b Invasive Melanoma Yields <1% Local Recurrence and Disease-specific Mortality
Dermatol Surg 2024 Sep 30;[EPub Ahead of Print], A Bangalore Kumar, T Trischman, E Asamoah, A Todd, NY Vidal, AM DemerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.